Navigation Links
Lung cancer molecular profile discovered by researchers.

According to a team of researchers an expression pattern of certain microRNA’s heve been found that can predict tumour aggressiveness in lunch cancer patients.//

The analysis of these findings indicates that miRNAs may represent a new class of diagnostic and prognostic tools for lung cancer.

The Ohio State University Comprehensive Cancer Centre, Columbus, Ohio; the Jikei University School of Medicine, Tokyo, Japan; National Cancer Centre Research Institute, Tokyo, Japan; and the Centre for Cancer Research at the National Cancer Institute (NCI), which is part of the National Institutes of Health have collaborated in the study.

As the name suggests, micro or miRNAs are small segments of genetic material called ribonucleic acid, or RNA, and are thought to control gene ex-pression.

Two miRNAs — has-mir-155 and has-let-7a-2 — have been identified that could be used as prognostic indicators in patients with adenocarcinoma, a malignancy of the mucous glands in the lungs.

A tumour with an overex-pression of has-mir-155 or reduced ex-pression of has-let-7a-2 would indicate the need for aggressive chemotherapy or radiation treatments.

According to Curtis Harris, M.D., chief of the Laboratory of Human Carcinogenesis at NCI and co-leader of this study, “This study is significant because it provides another tool for studying prognosis that is independent of tumour stage. Following surgery, 50 to 60 percent of patients with stage I lung cancer will develop metastatic disease within five years. This may indicate that there are micrometastases that have not been detected by imaging, scanning or pathology. In the future, we can use miRNAs and other biological predictors to select patients who may need more aggressive treatment versus those who may not. Additional studies confirming these results are the next step before incorporating miRNA analysis into routine clinical practice.”

In the study, a total of 104 pairs of primary tumour tissues and corresponding non- cancerous lung tissues were examined. The tumour and corresponding normal tissues were obtained from the same patient to eliminate genetic differences between tumor and normal tissues.

In the words of Carlo Croce, M.D., chair of Molecular Virology, Immunology and Medical Genetics at The Ohio State University and study co-leader, “This is promising research and is the first study to link these miRNAs to lung cancer. We are proposing that has-mir-155 may be acting like an oncogene in lung cancer. Oncogenes control cell growth and, when mutated, can contribute to abnormal cell growth. “miRNAs control the ex-pression of a number of genes so if the miRNA is altered, this could lead to the alteration of a number of genes affecting malignant tumor growth. Although these results are encouraging, further testing is required to demonstrate the validity of using these markers for predicting patient outcomes.”
br>
'"/>




Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Want skin cancer? Please have a cigarette
3. New hope for cancer victims – will vaccine cure the deadly bug
4. Clintons new problem - Is the outgoing American president suffering from skin cancer?
5. Are cancer patients being taken for a ride?
6. Breast cancer treatment to be determined by gene test
7. Ductal lavage may detect early breast cancer
8. Beware of the oral patch! It could be cancer!!!
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Flottman Company ... outserts. As a means of expanding capabilities Flottman has added a G&K ... individually code professional inserts (PIs) and patient package inserts (PPIs) that will marry ...
(Date:12/9/2016)... Hills, CA (PRWEB) , ... December 09, 2016 ... ... for young adults, celebrated its 10th anniversary with the grand opening of the ... California. The successful event spanned two days, December 2-3, and was attended by ...
(Date:12/9/2016)... Fort Lee, NJ (PRWEB) , ... December 09, ... ... the 2016 Founders Ball at The Pierre Hotel in New York, NY, on ... 700 friends, benefactors, dignitaries and physicians attended the annual event, which raised over ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... ... December 08, 2016 , ... After ... officially opened registration today for its 33rd Annual Issues & Research Conference, ... , The theme of the conference is “Persistent Challenges and New Opportunities: Using ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 2016 Research and Markets has announced the addition ... report to their offering. ... The report also analyses the market by the following Technology Types: ... for the US, Canada , Japan ... Latin America , and Rest of World. ...
(Date:12/9/2016)... 9, 2016 aTyr Pharma, Inc. (Nasdaq: LIFE ... Physiocrine-based therapeutics to address severe, rare diseases, today announced that senior ... Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel in ... 2016, at 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma ...
(Date:12/9/2016)... 2016  Forge Therapeutics, Inc. today announced a ... EVT, TecDAX, ISIN: DE0005664809) to advance its novel ... of bacterial infections including those caused by drug ... attractive antibacterial target for more than the past ... starting points has hampered its progress. Forge has ...
Breaking Medicine Technology: